|   | ![]() Your Search for Cryptococcal Meningitis matched 1000 Documents (Page 1 of 34). You may want to refine your search. Results Indexed by relevance. |
| 1. |
AEGiS OI: Meningitis (100%) Abstract: The fungus -- <I>Cryptococcus neoformans</I> -- is a yeast-like fungus found in soil around the world. It is most common in soil contaminated by bird droppings. ... http://www.aegis.com/topics/oi/oi-meningitis.html File Name: oi-meningitis.html, Size: 5KB, Last Modified: Monday, January 12, 2009 at 9:53:39 PM |
| 2. |
AEGiS-Glasgow [1758-2652-11-S1-P252] PERIPHERAL BLOOD CD4+ T-LYMPHOCYTE COUNT INFLUENCES CEREBROSPINAL FLUID CELLULAR RESPONSE IN PATIENTS WITH HIV-RELATED CRYPTOCOCCAL MENINGITIS (100%) Abstract: This result suggests that, despite the advanced level of immunodeficiency observed in these patients, the peripheral blood CD4+ T-lymphocyte count has a major influence on the development of an inflammatory response in the CSF in patients with meningitis by Cryptococcus neoformans. ... http://www.aegis.com/conferences/hiv-glasgow/2008/1758-2652-11-s1-p252.html File Name: 1758-2652-11-s1-p252.html, Size: 8KB, Last Modified: Monday, November 10, 2008 at 7:00:01 AM |
| 3. |
Metabolic Changes in a Thai Treatment-Naive Population Starting Double-Boosted Protease Inhibitor Therapy (100%) Abstract: 24-Week Efficacy and safety of Nevirapine: 400 mg versus 600 mg based HAART in HIV-infected Patients with Active Tuberculosis Receiving Rifampicin W. Manosuthi1, A.Avihingsanon2, P. Kantipong3, C. Chuchotaworn4, S. Moolphate5, N. Yamada5, H. Yanai5, P. Phanuphak2 , D. Burger6 and K. Ruxrungtham 2,7 ... http://www.aegis.com/conferences/iashivpt/2007/moab102.ppt File Name: moab102.ppt, Size: 5486KB, Last Modified: Monday, July 23, 2007 at 6:29:23 AM |
| 4. |
Cryptococcal meningitis (100%) Abstract: Complete info about Cryptococcal meningitis & treatment for HIV & AIDS. ... http://www.aegis.com/factshts/network/simple/menin.html File Name: menin.html, Size: 6KB, Last Modified: Monday, August 28, 2006 at 8:13:25 AM |
| 5. |
ADAP drugs: fluconazole (100%) Abstract: fluconazole. Diflucan). Drug description Fluconazole is used for treating. fungal infections. such as Candida albicans and Cryptococcal meningitis. Candida infection can show up as thrush in the mouth, or vaginal candidiasis. Cryptococcal meningitis is inflammation of the linings of the brain or spinal cord. Most peop ... http://www.aegis.com/factshts/network/simple/fluc.html File Name: fluc.html, Size: 4KB, Last Modified: Sunday, August 20, 2006 at 10:21:07 PM |
| 6. |
[ThPE0080] CRYPTOCOCCAL COMPLICATIONS IN THE FIRST YEAR ON HAART: EXPERIENCES OF A SOUTH AFRICAN ANTIRETROVIRAL PROGRAMME (100%) Abstract: Survival of patients with cryptococcal meningitis in Soweto is significantly improved with HAART. However, in this series, we encountered more cryptococcal IRD with higher mortality rates as compared with those seen in developed countries. Clarity on the optimal management of cryptococcal IRD is needed. ... http://www.aegis.com/conferences/iac/2006/thpe0080.html File Name: thpe0080.html, Size: 9KB, Last Modified: Sunday, August 13, 2006 at 7:00:01 AM |
| 7. |
[MoPe11.6C14] ETIOLOGY OF SECONDARY HEADACHE IN AN OUT-PATIENT HIV CLINIC AT MULAGO NATIONAL HOSPITAL KAMPALA UGANDA (100%) Abstract: Acute sinusitis and cryptococcal meningitis account for up to half (50%) of secondary headaches in HIV out-patients in Uganda. At least 75% of the causes of headache are readily diagnosed and treated in a resource-poor setting without head CT scans. The outpatient mortality in patients with cryptococcal meningitis was ... http://www.aegis.com/conferences/iashivpt/2005/mope11-6c14.html File Name: mope11-6c14.html, Size: 9KB, Last Modified: Monday, July 25, 2005 at 6:29:23 AM |
| 8. |
AEGiS-15IAC: Causes of admission and death as ARV use increases at joint clinical research center-comparision of four periods. (100%) Abstract: BACKGROUND: The Joint clinical Research Center has pioneered the use of Antiretroviral drugs in Uganda as well as offering comprehensive care to patients with HIV/AIDS. To date, over 12,000 have received ARVs at the center. This is just one percent of all the patients in Uganda who need ARVs. As such management of oppo ... http://www.aegis.com/conferences/iac/2004/b10222.html File Name: b10222.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 9. |
AEGiS-15IAC: Clinical profile and outcome of cryptococcal meningitis in Ethiopian AIDS patients treated under local conditions. (100%) Abstract: BACKGROUND: Cryptococcal meningitis is the most common life-threatening fungal infection in patients with AIDS. In Sub-sharan Africa it is one of the commonest opportunistic infections overall. This study was undertaken to assess the clinical profile and management outcome of microbiologically confirmed cryptococcal me ... http://www.aegis.com/conferences/iac/2004/moorb1017.html File Name: moorb1017.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 10. |
AEGiS-15IAC: Impact of Diflucan donation on the management of HIV/AIDS and capacity building of healthcare workers. (100%) Abstract: ISSUESManaging an HIV/AIDS patient resource limited settings is one of the biggest challenge facing the healthcare providers (HCP) regarding skills and morale, the drug management, and the referral system. Traditional healers who play a crucial role in the community usually keep their clients until late before been tak ... http://www.aegis.com/conferences/iac/2004/e12530.html File Name: e12530.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 11. |
AEGiS-15IAC: Randomized open labeled comparative study between amphotericin B plus fluconazole versus amphotericin B plus itraconazole versus amphotericin B alone for treatment of cryptococcal meningitis in AIDS. (100%) Abstract: OBJECTIVE: To explore the early clinical and mycological outcome of combination between amphotericin B and azoles in treatment of cryptococcal meningitis in AIDS. METHOD: This is a randomized, comparative controlled trial, which assigned patients with first episode of AIDS-associated cryptococcal meningitis to treatmen ... http://www.aegis.com/conferences/iac/2004/mopeb3232.html File Name: mopeb3232.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM |
| 12. |
AEGiS-10CROI: Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients Treated with HAART: A Multi-center Observational Study. (100%) Abstract: <p><b>BACKGROUND:</b> HAART has decreased the incidence of new episodes and recurrences of opportunistic infections in patients with AIDS. A few data are available concerning discontinuation of maintenance therapy for cryptococcal meningitis. </p> <p><b>METHODS:</b> This is an observational study. Inclusion criteria w ... http://www.aegis.com/conferences/croi/2003/799.html File Name: 799.html, Size: 7KB, Last Modified: Monday, February 10, 2003 at 8:12:04 PM |
| 13. |
[MoPeB3221] Efavirenz-based regimen in advanced AIDS with cryptococcal meningitis: A prospective multicenter study (100%) Abstract: In the developing countries, the patients often present late with advanced AIDS and major OIs. Cryptococcal meningitis is a common OI and usually occurs in patients with low CD4 (<100). The efficacy of antiretroviral therapy in advanced AIDS is noted but that and tolerability in advanced cases with recent episode of se ... http://www.aegis.com/conferences/iac/2002/mopeb3221.html File Name: mopeb3221.html, Size: 6KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM |
| 14. |
AEGiS-14IAC: Discontinuation of maintenance therapy for cryptococcal meningitis in patients treated with HAART: a multicentre observational study. (100%) Abstract: <p><b>BACKGROUND:</b> HAART has decreased the incidence of new episodes and recurrences of opportunistic infections in patients with AIDS. At this time, only anecdotal data are available concerning discontinuation of maintenance therapy for cryptococcal meningitis. </p> <p><b>METHODS:</b> The main inclusion criteria ... http://www.aegis.com/conferences/iac/2002/thpeb7287.html File Name: thpeb7287.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM |
| 15. |
AEGiS-14IAC: Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-Infected patients treated with HAART: A prospective multicenter randomized study. (100%) Abstract: <p><b>BACKGROUND:</b> Preliminary data from small studies suggest that as with other OIs ( PCP , disseminated MAC infection, CMV retinitis, and toxoplasmosis), cryptococcal meningitis may be possible to stop secondary prophylaxis in patients whose CD4 lymphocyte count rises with antiretroviral therapy. ... http://www.aegis.com/conferences/iac/2002/thpeb7292.html File Name: thpeb7292.html, Size: 8KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM |
| 16. |
AEGiS-14IAC: The treatment of cryptococcal meningitis at Centre de Traitement Ambulatoire de Pointe-Noire. (100%) Abstract: <p><b>BACKGROUND:</b> Among the factus that decrease the situation of HIV patients, we can find at a good place cryptococcal infection mainly when located in meningitis. In Africa, mainly at Pointe-Noire, HAART are not available and protocols against cryptococcal meningitis are not easy to conduct. We will share the ... http://www.aegis.com/conferences/iac/2002/b10254.html File Name: b10254.html, Size: 7KB, Last Modified: Monday, July 08, 2002 at 6:29:23 AM |
| 17. |
AEGiS-9CROI: Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients Treated with HAART: A Multicentre Observational Study. (100%) Abstract: BACKGROUND: HAART has decreased the incidence of new episodes and recurrences of opportunistic infections in patients with AIDS. At this time, only anecdotal data are available concerning discontinuation of maintenance therapy for cryptococcal meningitis. METHODS: The main inclusion criteria were a previous definitive ... http://www.aegis.com/conferences/croi/2002/635-w.html File Name: 635-w.html, Size: 6KB, Last Modified: Sunday, February 24, 2002 at 8:12:04 PM |
| 18. |
AEGiS-08CROI: Discontinuation or continuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with HAART. (100%) Abstract: <p><b>BACKGROUND:</b> HAART has decreased the incidence of new episodes and recurrences of opportunistic infections in patients with AIDS. Different studies showed that it could be considered safe to discontinue primary prophylaxis for PCP and MAC infections. At this time, no data are available concerning discontinuati ... http://www.aegis.com/conferences/croi/2001/546.html File Name: 546.html, Size: 7KB, Last Modified: Sunday, February 04, 2001 at 8:12:04 PM |
| 19. |
AEGiS-13IAC: Ocular manifestations of cryptococcal meningitis in African-American patients with AIDS in an inner city hospital. (100%) Abstract: <p><b>BACKGROUND:</b> Cryptococcal infection of the central nervous system is among the most frequently recognized life-threatening infections with AIDS. It manifests as meningitis or meningo-encephalitis. The neuro-ophthalmic manifestations of cryptococcal meningitis frequently reported include papilledema, optic at ... http://www.aegis.com/law/erences/iac/2000/mopeb2293.html File Name: mopeb2293.html, Size: 7KB, Last Modified: Sunday, July 09, 2000 at 8:12:04 PM |
| 20. |
AEGiS-13IAC: Risk factors predicting early mortality in AIDS patients with Cryptococcal Meningitis. (100%) Abstract: <p><b>BACKGROUND:</b> The prevalence of cryptococcal meningitis in AIDS patients in Africa is estimated at 30%. Mortality rates in developing countries are very high despite anti-fungal therapy. In a previous South African study on cryptococcal meningitis in AIDS patients, a 54% two week mortality was documented. Opt ... http://www.aegis.com/conferences/iac/2000/tupec3427.html File Name: tupec3427.html, Size: 7KB, Last Modified: Sunday, July 09, 2000 at 8:12:04 PM |
| 21. |
The impact of HIV on meningitis as seen at a South African Academic Hospital (1994 to 1998). (100%) Abstract: BACKGROUND: The increase in HIV infections in South Africa is alarming. The aim of this prospective 4-year study was to evaluate the rising incidence of HIV-related admissions due to meningitis at the Pretoria Academic Hospital (PAH) adult neurology ward and to investigate the spe ... http://www.aegis.com/pubs/ine/2000/jun/a0061935.html File Name: a0061935.html, Size: 9KB, Last Modified: Wednesday, June 28, 2000 at 8:12:04 PM |
| 22. |
Does the capsule component GXM of Cryptococcus neoformans impair tranthelial migration of leukocytes in patients with cryptococcal meningitis? (100%) Abstract: Background: Cryptococcus neoformans is the leading mycologic cause of central nervous system (CNS) disease in patients with suppressed cell-mediated immunity. We have demonstrated that cerebrospinal fluid (CSF) of patients with cryptococcal meningitis contains high levels of the neutrophil chemoattractant IL-8, despit ... http://www.aegis.com/pubs/ine/2000/may/a0050114.html File Name: a0050114.html, Size: 9KB, Last Modified: Sunday, May 28, 2000 at 8:12:04 PM |
| 23. |
Cerebrospinal fluid HIV-1 RNA levels in cryptococcal meningitis. Neuroscience of HIV Infection. (100%) Abstract: Background and Objectives: We report cerebrospinal fluid (CSF) and plasma HIV-1 RNA levels in 3 AIDS patients who had cryptococcal meningitis, 2 of whom died. Methods: HIV-1 RNA levels were performed using the Amplicor HIV-1 Monitor assay. Results: RP is a 28 year old male who had a simultaneous CSF viral load of 48,1 ... http://www.aegis.com/aidsline/2000/jan/a0010133.html File Name: a0010133.html, Size: 9KB, Last Modified: Friday, January 28, 2000 at 8:12:04 PM |
| 24. |
Efficacy and adverse effects of higher dose amphotericin B monotherapy for cryptococcal meningitis in patients with advanced HIV infection. (100%) Abstract: Treatment with a low daily dose of amphotericin B (0.4 mg/kg) in AIDS patients with cryptococcal meningitis has been associated with low efficacy and high mortality. We report our successful clinical experiences on a higher daily dose of amphotericin B (0.8-1.0 mg/kg) monotherapy in treating cryptococcal meningitis fr ... http://www.aegis.com/pubs/ine/1999/dec/a99c0815.html File Name: a99c0815.html, Size: 9KB, Last Modified: Tuesday, December 28, 1999 at 8:12:04 PM |
| 25. |
Risk factors for cryptococcal meningitis in HIV-infected patients. (100%) Abstract: To identify the risk factors for cryptococcal meningitis in patients with HIV disease we conducted a nested case-control study of 37 incident cases of cryptococcal meningitis and 74 controls, identified from a cohort of more than 2000 HIV-infected patients. Conditional logistic regression was used to study demographic ... http://www.aegis.com/aidsline/1999/oct/a99a0697.html File Name: a99a0697.html, Size: 10KB, Last Modified: Thursday, October 28, 1999 at 8:12:04 PM |
| 26. |
Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis. (100%) Abstract: Persistently elevated intracranial pressure (ICP) is one of the most accurate predictors of a poor prognosis in patients with AIDS-related cryptococcal meningitis. We present a severe case of persistent cryptococcal meningitis in a patient with advanced AIDS, complicated by elevation of ICP. A ventriculoperitoneal shu ... http://www.aegis.com/aidsline/1999/sep/a9990190.html File Name: a9990190.html, Size: 9KB, Last Modified: Tuesday, September 28, 1999 at 8:12:04 PM |
| 27. |
Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. (100%) Abstract: Hydrocephalus can be associated with increased morbidity and mortality in cryptococcal meningitis if left untreated. Both ventriculoperitoneal and ventriculoatrial shunting have been used in persons with cryptococcosis complicated by hydrocephalus, but the indications for and complications, success, and timing of thes ... http://www.aegis.com/pubs/ine/1999/aug/a9980161.html File Name: a9980161.html, Size: 9KB, Last Modified: Saturday, August 28, 1999 at 8:12:04 PM |
| 28. |
Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis. (100%) Abstract: RATIONALE: The incidences of HIV-AIDS patients with opportunistic infections of the central nervous system are increasing. Of these, cryptococcal meningitis is the most important and serious. A simple method for the diagnosis of cryptococcal meningitis is needed despite its variable clinical features and the lack of a ... http://www.aegis.com/aidsline/1999/jun/a9960514.html File Name: a9960514.html, Size: 10KB, Last Modified: Monday, June 28, 1999 at 8:12:04 PM |
| 29. |
Few Risk Factors Identified for AIDS-Related Cryptococcal Meningitis (100%) Abstract: Investigators from Johns Hopkins University report in the May issue of AIDS Research and Human Retroviruses that gender, race, and steroid exposure are unlikely to influence the risk of AIDS-related cryptococcal meningitis. These factors have been thought to predispose one to the opportunistic infection. However, resea ... http://www.aegis.com/news/ads/1999/ad990872.html File Name: ad990872.html, Size: 9KB, Last Modified: Thursday, May 27, 1999 at 3:00:00 PM |
| 30. |
A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients. (100%) Abstract: To evaluate the efficacy and safety of Amphotericin B dissolved in dextrose (Amb) or in a lipid emulsion (Intralipid, Amb-IL) in AIDS patients with cryptococcal meningitis, we conducted a retrospective study in 30 AIDS patients with cryptococcal meningitis. A clinical complete resolution was obtained in 11 patients (5 ... http://www.aegis.com/pubs/ine/1999/feb/a9920450.html File Name: a9920450.html, Size: 9KB, Last Modified: Sunday, February 28, 1999 at 8:12:04 PM |
|   |
|
|   |
|